Humacyte, Inc. (HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.
Humacyte, Inc. (HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.